Hepatitis type C treatments are expected to be the hot issue in the industry

Hepatitis type C treatments, attracting attention in the industry concerned, will become the hot issue in the second half of the year.

There is a higher chance the second generation hepatitis type B treatments will cause publiccontroversies on a process of the insurance benefit registration as it will form expensive drug price due to its high effectiveness.

Companies owing the second generati...